Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01544049 · ClinicalTrials.gov registry record
Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
A clinical trial, sponsored by University of Washington.
- Completed
- Registry status
- 24
- Enrollment target
NCT01544049: Completed study, sponsored by University of Washington.
NCT01544049 is a clinical trial that has completed, run by University of Washington. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01544049 has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel women about ovarian cancer prevention.
Primary Outcome
Subjects will provide information on their reason for choosing salpingectomy and the process they went through in undergoing this procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-12 |
| Est. Completion | 2018-09-04 |
What the finished NCT01544049 record still lists
NCT01544049 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01544049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01544049 about?
NCT01544049 is a clinical study titled "Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study". The purpose of this study is to better understand why women choose to have their fallopian tubes removed as a method for ovarian cancer prevention. This will be done through a paper questionnaire and phone interviews. The investigators hope to gain information that will allow us to better counsel wo...
What is the current status of trial NCT01544049?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2011-12. Estimated completion is 2018-09-04.
Who is sponsoring clinical trial NCT01544049?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia